Albuterol FDA Approved Drugs
ACCUNEB [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.021% base (inhalation solution)
eq 0.042% base (inhalation solution)
Mylan Speciality LpApr 30, 2001
- Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease).
ALBUTEROL SULFATE [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.021% base (inhalation solution)
eq 0.042% base (inhalation solution)
eq 0.083% base (inhalation solution)
eq 0.5% base (inhalation solution)
eq 2mg base (oral tablet)
eq 2mg base/5ml (oral syrup)
eq 4mg base (oral tablet)
eq 8mg base (oral tablet, extended release)
NephronMar 31, 2010
Watson LabsSep 25, 2007
Ritedose CorpDec 16, 2008
Bausch And LombJun 18, 1998
Hi Tech PharmaJan 15, 1998
MylanJan 17, 1991
Sun Pharm IndsDec 5, 1989
Amneal PharmsMay 12, 2010
G And W Labs IncSep 25, 1995
TevaMar 30, 1992
VintageDec 27, 2006
VistapharmJun 26, 2007
Watson LabsSep 25, 2007
Ritedose CorpDec 16, 2008
Bausch And LombJun 18, 1998
Hi Tech PharmaJan 15, 1998
MylanJan 17, 1991
Sun Pharm IndsDec 5, 1989
Amneal PharmsMay 12, 2010
G And W Labs IncSep 25, 1995
TevaMar 30, 1992
VintageDec 27, 2006
VistapharmJun 26, 2007
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE [Albuterol Sulfate2C13H21NO3H2O4S : Ipratropium BromideC20H30NO3BrH2O]
RX
- eq 0.083% base : 0.017% (inhalation solution)
Cipla LtdDec 31, 2007
NephronDec 31, 2007
Ritedose CorpOct 1, 2012
Teva PharmsDec 31, 2007
Watson Labs TevaDec 31, 2007
NephronDec 31, 2007
Ritedose CorpOct 1, 2012
Teva PharmsDec 31, 2007
Watson Labs TevaDec 31, 2007
COMBIVENT RESPIMAT [Albuterol Sulfate2C13H21NO3H2O4S : Ipratropium BromideC20H30NO3BrH2O]
RX
- eq 0.1mg base/inh : 0.02mg/inh (inhalation spray, metered)
Boehringer IngelheimOct 7, 2011
LEVALBUTEROL HYDROCHLORIDE [Levalbuterol HydrochlorideC13H21NO3ClH]
RX
- eq 0.0103% base (inhalation solution)
eq 0.021% base (inhalation solution)
eq 0.042% base (inhalation solution)
eq 0.25% base (inhalation solution)
Aurobindo Pharma LtdDec 30, 2016
Cipla LtdDec 13, 2013
Impax Labs IncApr 9, 2008
Mylan Speciality LpMar 15, 2013
Ritedose CorpMar 22, 2016
Teva Pharms UsaApr 26, 2013
Teva ParenteralSep 11, 2014
Cipla LtdDec 13, 2013
Impax Labs IncApr 9, 2008
Mylan Speciality LpMar 15, 2013
Ritedose CorpMar 22, 2016
Teva Pharms UsaApr 26, 2013
Teva ParenteralSep 11, 2014
PROAIR HFA [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.09mg base/inh (inhalation aerosol, metered)
Teva Branded PharmOct 29, 2004
PROAIR RESPICLICK [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.090mg base/inh (inhalation powder, metered)
Teva Branded PharmMar 31, 2015
PROVENTIL-HFA [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.09mg base/inh (inhalation aerosol, metered)
3m Drug DeliveryAug 15, 1996
VENTOLIN HFA [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 0.09mg base/inh (inhalation aerosol, metered)
GlaxosmithklineApr 19, 2001
- The treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airways disease and the prevention of exercised-induced bronchospasm in patients 4 years of age and older.
VOSPIRE ER [Albuterol Sulfate2C13H21NO3H2O4S]
RX
- eq 4mg base (oral tablet, extended release)
eq 8mg base (oral tablet, extended release)
Dava Pharms IncSep 26, 2002
XOPENEX [Levalbuterol HydrochlorideC13H21NO3ClH]
RX
- eq 0.0103% base (inhalation solution)
eq 0.021% base (inhalation solution)
eq 0.042% base (inhalation solution)
eq 0.25% base (inhalation solution)
Oak Pharms IncJan 30, 2002
XOPENEX HFA [Levalbuterol Tartrate2C13H21NO3C4H6O6]
RX
- eq 0.045mg base/inh (inhalation aerosol, metered)
SunovionMar 11, 2005
- Treatment or prevention of bronchospasm or asthmatic symptoms.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.